Mainline Biosciences (Shanghai) Co., Ltd
Mainline Biosciences (Shanghai) Co., Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2025-12-02 | NCT06840821 |